Reviva Pharmaceuticals Q1 EPS $(0.46) Beats $(0.62) Estimate
Benzinga Newsdesk 6 months ago
EarningsEarnings BeatsNews
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.62) by 25.81 percent. This is a 82.31 percent increase over losses of $(2.60) per share
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.62) by 25.81 percent. This is a 82.31 percent increase over losses of $(2.60) per share from the same period last year.